<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Cardiovascular</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/184E27B1-23BB-42E1-8E9D-2FC5BB12F5B1"><gtr:id>184E27B1-23BB-42E1-8E9D-2FC5BB12F5B1</gtr:id><gtr:firstName>Manuel</gtr:firstName><gtr:surname>Mayr</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/EA8C975A-0C94-4BCE-82DA-19D4FA26832D"><gtr:id>EA8C975A-0C94-4BCE-82DA-19D4FA26832D</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:otherNames>Stephen</gtr:otherNames><gtr:surname>Marber</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G1000737"><gtr:id>FB98D887-6FCB-4672-A695-4668BB32E557</gtr:id><gtr:title>The validation of cMyBP-C as a new diagnostic marker of myocardial infarction</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1000737</gtr:grantReference><gtr:abstractText>Only a small proportion of patients with chest pain have acute myocardial infarction (MI). Although the ECG provides a very useful immediate test often patients have to be admitted in order to be sure they are not having an MI. The diagnosis of MI is made by the release of cardiac proteins known as troponins. These proteins are released slowly into the blood and also disapear slowly from the blood. The consequence is that patients need to be kept in hospital for at least 12 hours to make sure troponins do not appear in their blood. Furthermore once they do appear, and a diagnosis of MI is made, it can be difficult to know if patients are having further MIs because the troponins stay elevated after the first MI. The purpose of this application is to determine if another cardiac protein, known as cardiac myosin binding protein C, is released more quickly and/or cleared more quickly than troponin.</gtr:abstractText><gtr:technicalSummary>Acute myocardial infarction (AMI) is the most common cause for death and effective treatments are available providing diagnosis is rapid. The current diagnostic gold standard is the appearance in the serum of cardiac troponin I or T. However, their slow release delays diagnosis, their persistence limits their utility in the identification of reinfarction and they have low specificity when used at their population-defined lower limit of normality. Our aim is to qualify and validate a potential new biomarker of AMI known as cardiac myosin binding protein C (cMyBP-C) that we have identified through our research and is the intellectual property of KCL. The validation will comprise 2 steps. The first is to use our current test on blood samples taken at frequent intervals from 20 patients with suspected AMI to compare the temporal profile of the troponins with our new marker. The second is to further develop and test methods to detect post-translational modifications of cMyBP-C which may better define the cardiac pathology responsible for release.</gtr:technicalSummary><gtr:fund><gtr:end>2013-10-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>411632</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Hosting 4 work experience students each for one week</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>A3D1FFEE-B640-4709-ABD7-6D6436DA4631</gtr:id><gtr:impact>Formal feedback good to excellent all domains

Schools requested repeat placements for next year</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012,2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>use of MyBP-C to diagnose MI</gtr:description><gtr:id>B31D4B9E-F558-44A2-A711-3396ACF7459C</gtr:id><gtr:impact>None as yet</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:patentId>US8546089</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>US patent for diagnosis of myocardial injury</gtr:title><gtr:yearProtectionGranted>2012</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>The use of novel cardiac porteins that are reaeased in to the blood to diagnose injury</gtr:description><gtr:id>4C51831C-2C15-4B7C-B2B7-E904174FD4DB</gtr:id><gtr:impact>Release of cMyB-C is more rapid than troponin</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:patentId>WO2010130985 (A1)</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>cMyBP-C and MLC2 as diagnostic markers of cardiac injury</gtr:title><gtr:yearProtectionGranted>2010</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>An ELISA to detect cMyBP-C in serum. Still requires validation</gtr:description><gtr:id>07F43DDF-D17D-44AC-AEA9-EF0DCD6537CE</gtr:id><gtr:impact>None</gtr:impact><gtr:stage>Initial development</gtr:stage><gtr:status>Actively seeking support</gtr:status><gtr:title>ELISA</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2011</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>high affinity antibodies to N-terminus of cMyBP-C</gtr:description><gtr:id>57A09C34-BB2A-4AED-90C5-4583EE2665FF</gtr:id><gtr:impact>Few as yet being used within group for EIA</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>mAb C0C2</gtr:title><gtr:type>Antibody</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/44055BE2-22CB-484E-8DFE-02A2D0BCE9D6"><gtr:id>44055BE2-22CB-484E-8DFE-02A2D0BCE9D6</gtr:id><gtr:title>Meeting report from the 2nd International Symposium on New Frontiers in Cardiovascular Research. Protecting the cardiovascular system from ischemia: between bench and bedside.</gtr:title><gtr:parentPublicationTitle>Basic research in cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b491d033f73026e0d3a2b11ac68b4aa0"><gtr:id>b491d033f73026e0d3a2b11ac68b4aa0</gtr:id><gtr:otherNames>Cabrera-Fuentes HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0300-8428</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5C75FBE8-4157-4995-943C-C566BE69E656"><gtr:id>5C75FBE8-4157-4995-943C-C566BE69E656</gtr:id><gtr:title>The development and application of a high-sensitivity immunoassay for cardiac myosin-binding protein C.</gtr:title><gtr:parentPublicationTitle>Translational research : the journal of laboratory and clinical medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4f804f322605c774308bae4229626320"><gtr:id>4f804f322605c774308bae4229626320</gtr:id><gtr:otherNames>Marjot J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1878-1810</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/517274A6-ECCC-493F-95D4-458D5FBE3EDD"><gtr:id>517274A6-ECCC-493F-95D4-458D5FBE3EDD</gtr:id><gtr:title>Cardiac myosin-binding protein C: a potential early biomarker of myocardial injury.</gtr:title><gtr:parentPublicationTitle>Basic research in cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3dd01bba696a4b07434703b50889b1bd"><gtr:id>3dd01bba696a4b07434703b50889b1bd</gtr:id><gtr:otherNames>Baker JO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0300-8428</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/613881F3-8B21-441E-B19F-008493518935"><gtr:id>613881F3-8B21-441E-B19F-008493518935</gtr:id><gtr:title>Gadd45? regulates cardiomyocyte death and post-myocardial infarction left ventricular remodelling.</gtr:title><gtr:parentPublicationTitle>Cardiovascular research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fb0f22304a03c5a9bc6a2b4948ab99ff"><gtr:id>fb0f22304a03c5a9bc6a2b4948ab99ff</gtr:id><gtr:otherNames>Lucas A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0008-6363</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B08C5272-6CDA-4A06-A35E-DF52EEB113C2"><gtr:id>B08C5272-6CDA-4A06-A35E-DF52EEB113C2</gtr:id><gtr:title>Troponins: redefining their limits.</gtr:title><gtr:parentPublicationTitle>Heart (British Cardiac Society)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3dd01bba696a4b07434703b50889b1bd"><gtr:id>3dd01bba696a4b07434703b50889b1bd</gtr:id><gtr:otherNames>Baker JO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1355-6037</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1000737</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>89AE580F-2437-4540-9640-37005C968E67</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>4.1  Discovery and preclinical testing of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>